{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:17:07Z","timestamp":1787797027092,"version":"build-2784847793"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lung Therapeutics Inc.","award":["Consultancy"],"award-info":[{"award-number":["Consultancy"]}]},{"name":"Lung Therapeutics Inc.","award":["Consultancy"],"award-info":[{"award-number":["Consultancy"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03782-4","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:13:14Z","timestamp":1781709194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The LTI-01-2001 phase 2a trial of intrapleural LTI-01 in patients with infected, non-draining pleural effusions"],"prefix":"10.1186","volume":"27","author":[{"given":"Carla R","family":"Lamb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Akulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Musani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Shojaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushan","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Senitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momen","family":"Wahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikandar","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhanned","family":"Abu-Hijleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Puchalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonny","family":"Yarmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Kheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Singh P.","family":"Karan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Windsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib M","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Idell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"3782_CR1","doi-asserted-by":"publisher","first-page":"L757","DOI":"10.1152\/ajplung.00501.2017","volume":"314","author":"AA Komissarov","year":"2018","unstructured":"Komissarov AA, Rahman N, Lee YCG, Florova G, Shetty S, Idell R, Ikebe M, Das K, Tucker TA, Idell S. Fibrin turnover and pleural organization: bench to bedside. Am J Physiol Lung Cell Mol Physiol. 2018;314:L757\u201368.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3782_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1172\/JCI102046","volume":"28","author":"WS Tillett","year":"1949","unstructured":"Tillett WS, Sherry S, The effect in patients of streptococcal fibrinolysin (streptokinase). and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest. 1949;28:173\u201390.","journal-title":"J Clin Invest"},{"key":"3782_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/00031348251331281","volume":"91","author":"HA Siddiqui","year":"2025","unstructured":"Siddiqui HA, Maginot ER, Moody TB, Henry R, Barrett CD. Pleural Space Diseases and Their Management: What is the Role of Intrapleural Fibrinolytic Therapy? Am Surg. 2025;91:1036\u201345.","journal-title":"Am Surg"},{"key":"3782_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1513\/AnnalsATS.201711-848PS","volume":"15","author":"S Idell","year":"2018","unstructured":"Idell S, Rahman NM. Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns. Ann Am Thorac Soc. 2018;15:515\u20137.","journal-title":"Ann Am Thorac Soc"},{"key":"3782_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa1012740","volume":"365","author":"NM Rahman","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518\u201326.","journal-title":"N Engl J Med"},{"key":"3782_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1164\/rccm.200204-313OC","volume":"166","author":"S Idell","year":"2002","unstructured":"Idell S, Mazar A, Cines D, Kuo A, Parry G, Gawlak S, Juarez J, Koenig K, Azghani A, Hadden W, et al. Single-Chain Urokinase Alone or Complexed to Its Receptor in Tetracycline-induced Pleuritis in Rabbits. Am J Respir Crit Care Med. 2002;166:920\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"3782_CR7","doi-asserted-by":"publisher","first-page":"L389","DOI":"10.1152\/ajplung.00171.2016","volume":"311","author":"AA Komissarov","year":"2016","unstructured":"Komissarov AA, Florova G, Azghani AO, Buchanan A, Boren J, Allen T, Rahman NM, Koenig K, Chamiso M, Karandashova S, et al. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models. Am J Physiol Lung Cell Mol Physiol. 2016;311:L389\u2013399.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3782_CR8","doi-asserted-by":"publisher","unstructured":"Beckert L, Brockway B, Simpson G, Southcott AM, Lee YCG, Rahman N, Light RW, Shoemaker S, Gillies J, Komissarov AA, et al. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema. JCI Insight. 2019;5(10):e127470. https:\/\/doi.org\/10.1172\/jci.insight.127470.","DOI":"10.1172\/jci.insight.127470"},{"key":"3782_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1378\/chest.13-1558","volume":"145","author":"NM Rahman","year":"2014","unstructured":"Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014;145:848\u201355.","journal-title":"Chest"},{"key":"3782_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1164\/rccm.200312-1740OC","volume":"170","author":"AH Diacon","year":"2004","unstructured":"Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004;170:49\u201353.","journal-title":"Am J Respir Crit Care Med"},{"key":"3782_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1183\/09031936.00147214","volume":"46","author":"CE Hooper","year":"2015","unstructured":"Hooper CE, Edey AJ, Wallis A, Clive AO, Morley A, White P, Medford AR, Harvey JE, Darby M, Zahan-Evans N, Maskell NA. Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection. Eur Respir J. 2015;46:456\u201363.","journal-title":"Eur Respir J"},{"key":"3782_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1164\/rccm.202305-0854OC","volume":"208","author":"EO Bedawi","year":"2023","unstructured":"Bedawi EO, Stavroulias D, Hedley E, Blyth KG, Kirk A, De Fonseka D, Edwards JG, Internullo E, Corcoran JP, Marchbank A, et al. Early Video-assisted Thoracoscopic Surgery or Intrapleural Enzyme Therapy in Pleural Infection: A Feasibility Randomized Controlled Trial. The Third Multicenter Intrapleural Sepsis Trial-MIST-3. Am J Respir Crit Care Med. 2023;208:1305\u201315.","journal-title":"Am J Respir Crit Care Med"},{"key":"3782_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1513\/AnnalsATS.201407-329OC","volume":"11","author":"F Piccolo","year":"2014","unstructured":"Piccolo F, Pitman N, Bhatnagar R, Popowicz N, Smith NA, Brockway B, Nickels R, Burke AJ, Wong CA, McCartney R, et al. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Ann Am Thorac Soc. 2014;11:1419\u201325.","journal-title":"Ann Am Thorac Soc"},{"key":"3782_CR14","doi-asserted-by":"publisher","first-page":"L682","DOI":"10.1152\/ajplung.00102.2013","volume":"305","author":"AA Komissarov","year":"2013","unstructured":"Komissarov AA, Florova G, Azghani A, Karandashova S, Kurdowska AK, Idell S. Active alpha-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids. Am J Physiol Lung Cell Mol Physiol. 2013;305:L682\u201392.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3782_CR15","doi-asserted-by":"crossref","unstructured":"Bedawi EO, Kanellakis NI, Corcoran JP, Zhao Y, Hassan M, Asciak R, Mercer RM, Sundaralingam A, Addala DN, Miller RF, et al. The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study. Am J Respir Crit Care Med. 2023;207(6):731\u201339.","DOI":"10.1164\/rccm.202206-1084OC"},{"key":"3782_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1183\/09031936.03.00086202","volume":"22","author":"YC Lee","year":"2003","unstructured":"Lee YC, Lane KB, Zoia O, Thompson PJ, Light RW, Blackwell TS. Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells. Eur Respir J. 2003;22:197\u2013202.","journal-title":"Eur Respir J"},{"key":"3782_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1440-1843.2004.00633.x","volume":"9","author":"SE Mutsaers","year":"2004","unstructured":"Mutsaers SE, Prele CM, Brody AR, Idell S. Pathogenesis of pleural fibrosis. Respirology. 2004;9:428\u201340.","journal-title":"Respirology"},{"key":"3782_CR18","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.chest.2022.06.008","volume":"162","author":"J Akulian","year":"2022","unstructured":"Akulian J, Bedawi EO, Abbas H, Argento C, Arnold DT, Balwan A, Batra H, Uribe Becerra JP, Belanger A, Berger K, et al. Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study. Chest. 2022;162:1384\u201392.","journal-title":"Chest"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03782-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03782-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03782-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:18:19Z","timestamp":1787793499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03782-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3782"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03782-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9348224\/v1","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received Institutional Review Board approval from all participating institutions prior to study initiation. All subjects provided written informed consent prior to participation. This trial was conducted in accordance with ethical principles from the Declaration of Helsinki, and clinical research guidelines established by the United States Code of Federal Regulations (21 CFR Parts 50, 56, and 312) and the International Conference on Harmonisation (ICH) E6(R1) Guideline for Good Clinical Practice (GCP).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Competing interests. Dr. Idell founded Lung Therapeutics, Inc. (LTI), which was acquired by Aileron, Inc, now called Rein Therapeutics, Inc. He has an equity position in Rein and received compensation as Chief Scientific Officer for LTI until about 2021. He remains a consultant for LTI, paid through about 2021. His declared conflicts of interest are managed through the UTHSCT and the UT System. He is an inventor on a relevant patent (USPTO 7332469) held by the UT Board of Regents and licensed to LTI. Drs. Rahman and Sheomaker have received consultancy fees from Lung Therapeutics, Inc. Dr. Windsor is President and Chief Executive Officer at Rein Therapeutics Inc. rebranded from Aileron, Inc., which acquired LTI and LTI before that, and is a director (since 2013) who receives equity and financial compensation for his roles at the company. Dr. Kurman has received grants from Biodesix, CSA Medical, Galvanize, Medtronic, Nuvaira, PrognomiQ, Pulmonx, and Veracyte and has served as a consultant for Ambu, Biodesix, Circulogene, Cook, Galvanize, Intuitive, Medtronic, Merit, Noah Medical, Pinnacle Biologics, PrognomiQ, Pulmonx, Steris, Veracyte, and Verona Pharma. Dr. Musani has served as a consultant for Intuitive. He has received research grants from Galvanize, Pinnacle, Veracyte, and Biodesix and has shares in EON. ICJME conflict of interests forms are available for each author in the supplemental material.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"332"}}